Skip to main content
. 2016 Dec;74:363–370. doi: 10.1016/j.psyneuen.2016.09.019

Fig. 3.

Fig. 3

Treatment with ziprasidone dose-dependently enhanced the low startle response induced by 667-COUMATE administration (A). The highest dose of ziprasidone significantly reduced Nov/Ccn3 gene expression and increased Adcy8 expression in 667-COUMATE-treated mice (B). *p < 0.05.